Meet neffy: Health Canada approves epinephrine nasal spray for anaphylaxis

A bee collects pollen from a sunflower in a field on the outskirts of Frankfurt, Germany, Friday, Aug. 2, 2024. (AP Photo/Michael Probst)

TORONTO - Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called neffy.

ALK Canada, which purchased the rights to distribute the drug, says the two-milligram treatment has been approved for adults and pediatric patients who weigh at least 30 kilograms -- roughly 66 lbs.

¹ú²úÓÕ»ó¸£Àû

More National Stories

Sign Up to Newsletters

Get the latest from ¹ú²úÓÕ»ó¸£Àû News in your inbox. Select the emails you're interested in below.